Abstract
Objective To study the expression of ADAM8 in non-small cell lung cancer and the rela-tionship with their clinical pathology. Methods The expression of ADAMS was detected by tissue microarray and immunohistechemmistry technology in 96 specimens of NSCLC tissues ,36 specimens of adjacent lung tissues and 12 specimens of benign lung tissues. Results The positive rate of ADAMS expression in NSCLC tissues, adjacent lung tissues and benign lung tissues were 82. 29% (79/96), 11.11% (4/36). 16. 67% (2/12), re-spectively ;There was a significant difference among NSCLC tissues,adjacent lung tissues and benign lung tissues (P 0. 05) ; ADAM8 protein expression in NSCLC tissues was closely related to TNM stages,lymph node metastasis and dis-tant metastasis (P 0. 05). Conclusion The overexpression of ADAMS in NSCLC patients indicates that ADAMS is closely related to TNM stages, invasion and metastasis of NSCLC. Detection of ADAM8 protein may be helpful to evaluate bio-logical characteristics for NSCLC. Key words: ADAMS ; Non-small cell lung cancer; Microarray; Immunohistochemistry
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
